This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract has a ceiling value of $2,280 and is for the delivery of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and does not have a set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of...
This is a delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PURAPLY MICRONIZED, 500MG, a wound care product, with a ceiling value of $3,008. The contract has a fixed price with economic price adjustment pricing type and a completion date of June 10, 2025. Organogenesis is a key supplier of medical products, including skin substitutes,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $5,100.00, is for the supply of PURAPLY AM XT 4.91X4.91 medical products. This is not a set-aside contract, indicating Organogenesis competed as a standard commercial vendor. The contract is a fixed-price with economic price...
The U.S. Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract for PURAPLY AM (2x2) 4 SQ CM wound dressings. This is not a set-aside contract. Organogenesis is a for-profit manufacturer that has been awarded numerous prime federal contracts to provide wound care products, surgical implants, and tissue regeneration solutions to government agencies, including the Department of...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, to provide PURAPLY AM wound dressings to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,678.32 fixed-price with economic price adjustment delivery order has a period of performance through June 16, 2025. Organogenesis is an established supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract is a $1,140 fixed-price delivery order for PURAPLY MZ 500MG, a wound care product. The contract is not associated with a set-aside program and has an ultimate completion date of April 8, 2025. Organogenesis Inc. is a for-profit manufacturer that specializes in advanced wound care, surgical...
The U.S. government awarded a $3,400.00 fixed-price delivery order contract to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract is for the supply of PURAPLY AM XT EF, a 5-layer fenestrated wound dressing product, with a performance period ending on July 3, 2025. This award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is not a set-aside contract. Organogenesis is a manufacturer of advanced wound care,...